Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.58

+1.8%

Nov 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (1108)	6/20/2005 10:26:33 PM
From: Jibacoa	Read Replies (2) of 3722

Re: ARQL It was able to close above its May 26 H of 6.65 and the Jan.7-Jan.10 double top at 6.75 but there was some profit taking AHs.<g> bigcharts.marketwatch.com The next resistance is now at the May 2004 H of 6.87 and the April 30 2004 H at 7.85 before it can retest the April 8 2004 at 7.97 If it can do that it could get to test its April 2002 H at 12.70 <g> bigcharts.marketwatch.com ARQL reportedly has $2.45 in cash/share,its Debt/Eq.ratio is around 0.001 and was CF + (more than $9M) On its last Q revenues were up around 19% and the loss was cut to $0.04/shr vs $0.15/shr in 2004 However, the EL for 2005 is close to $0.70/shr vs. $0.16/shr in 2004 If that is right the coming reports will not look good in comparison, but perhaps the estimates are off.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next